Institutional investors purchased a net $17.2 million shares of TEVA during the quarter ended December 2014, and now own 55.24% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CARMIGNAC GESTION SA Bought 6.1 Million shares of Teva Pharmaceutical
FIDELITY MANAGEMENT & RESEARCH C... Bought 5.8 Million shares of Teva Pharmaceutical
ARROWSTREET CAPITAL LP Bought 4.8 Million shares of Teva Pharmaceutical